(2-Chloropyridin-3-yl)(3-methylpiperidin-1-yl)methanone

Catalog No. :
ACYNXI929
CAS No. :
560106-13-0
Molecular Formula :
C12H15ClN2O
Molecular Weight :
238.72

IUPAC Name:(2-chloropyridin-3-yl)(3-methylpiperidin-1-yl)methanone

(2-Chloropyridin-3-yl)(3-methylpiperidin-1-yl)methanone structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g95%$138.00Login to see priceInquiryInquiry
5g95%$414.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name(2-Chloropyridin-3-yl)(3-methylpiperidin-1-yl)methanone
IUPAC Name(2-chloropyridin-3-yl)(3-methylpiperidin-1-yl)methanone
MDL No.MFCD03385184
Molecular FormulaC12H15ClN2O
Molecular Weight238.72
SMILESO=C(C1=CC=CN=C1Cl)N2CC(C)CCC2
InChI KeyHGAPFNVAUJPHIR-UHFFFAOYSA-N
Synonym1-[(2-CHLORO-3-PYRIDINYL)CARBONYL]-3-METHYL-PIPERIDINE;(2-Chloropyridin-3-yl)(3-Methylpiperidin-1-yl)Methanone;Piperidine, 1-[(2-chloro-3-pyridinyl)carbonyl]-3-methyl- (9CI);Methanone, (2-chloro-3-pyridinyl)(3-methyl-1-piperidinyl)-
CAS No.560106-13-0

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACYNXI929 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACYNXI929 route product structure diagram
    ACYNXI929560106-13-0
Inquiry

2. ACYNXI929 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACCOGW615 route compound structure diagram
    ACCOGW61549609-84-9 In Stock
  4. Then
  5. ACYNXI929 route product structure diagram
    ACYNXI929560106-13-0
Inquiry

Comments (0)